Skip to content
SentinelMarket desk
Switch to dark mode

바이넥스

053030KOSDAQView the 제약 sectorTheme Bio & healthcare

6,120KRWMarket close of 10/22 (Thu)

Up +0.33%+20KRWMarket close of 10/22 (Thu)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/23 (Fri)6,180KRWUp +0.98%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
6,090
High
6,480
Low
6,000
Day range
Day range low 6,000 high 6,480, open 6,090, close 6,120, previous close 6,100
Volume
5×10K shares
305.09 million KRW 0.79× the 20-session average

Market close of 10/22 (Thu)

Where it sits in the 1-year range

1-year close range 5,740 to 16,400 won, 4% up from the low

4% of the way up from the lowest close in 1 year (252 sessions) · -62.7% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-14.0B KRWOperating income over the last four quarters -14.0B KRW (loss)Operating income, 8 quarters
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move+0.33%usual range
  • Trading value0.8×usual range
  • Data date10/22 (Thu)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue35.3B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -11.2%
    vs. prior quarter
    -9.0%
  • Operating income-9.0B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Turned to loss
    vs. prior quarter
    Still a loss
  • Operating margin-25.4%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -26.8 pp
    vs. prior quarter
    -9.1 pp

Quarterly operating income trend

As of the latest official close · 2026-10-22Valuation filing date · 2026-05-15
2021Q1 4.0B KRW2026Q1 -9.0B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Down -2.95%

· 13 of 168 stocks up, preferred shares excluded · trading value 587.7B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions -2.6%Down -3.95%104.4B KRW
셀트리온Close over the last 20 sessions +8.3%Down -1.67%101.7B KRW
지투지바이오Close over the last 20 sessions +29.2%Down -2.14%29.6B KRW
유한양행Close over the last 20 sessions +10.7%Down -3.00%28.7B KRW
한미약품Close over the last 20 sessions -26.3%Down -2.37%28.4B KRW

Schedule

  • Next data 10/26 (Mon) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 76% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.